Body Composition Monitor in Hemodialysis Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 160 participants.

Also called NCT01103167

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 160 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01103167
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01103167. Allocation not applicable; no masking; primary purpose treatment. Start 2010-04 (registry gives no type); primary completion 2010-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Body Composition Monitor in Hemodialysis Patients
Condition
End Stage Renal Disease
Intervention (Behavioral)
control of ultrafiltration
Lead sponsor
Gachon University Gil Medical Center (class: other)
Collaborator
Seoul National University Hospital (class: other)
Collaborator
Seoul National University Bundang Hospital (class: other)

Record details

Record id
cardio:ct-nct01103167
Content hash
82cb56c674aa50a5d90cff3c15a5dea1aa78d4305ae46db714242c1fd33f737a